10,000 ppm glutathione provides antioxidant protection against daily environmental stress
Developed by Novo Nordisk, this once-daily tablet is expected to receive FDA approval soon and become the first oral GLP-1 treatment for obesity
Esta observacin sugiere que la inhibicin de GLP-1 sobre la secrecin de glucagn involucra otro mecanismo adems de la accin inhibicin paracrina de la insulina sobre el glucagn (28,29)
Insulin + GLP-1: Can be combined, often allowing significant insulin dose reduction
However, it is important to note that their statistical analysis indicated that the statistical significance of the score improvements was stronger in the placebo group than it was in either of the treatment groups
First-Pass Metabolism The body has a process called "first-pass metabolism," where the liver and gut process substances before they reach the rest of the circulation